![Jakub Simon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Jakub Simon, Senior Director-Clinical Development at Merck & Co., Inc., and Chief Medical Officer at Vaxcyte, Inc. He holds a graduate degree from the University of Maryland and the University of California.
Eerdere bekende functies van Jakub Simon
| Bedrijven | Functie | Einde |
|---|---|---|
| VAXCYTE, INC. | Hoofd Techniek/Wetenschap/O&O | 30-04-2024 |
| MERCK & CO., INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Jakub Simon
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
1
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Kies MarketScreener 
